कोशिश गोल्ड - मुक्त
Our AI Chatbots Could Soon Be Acting as Advertising Vehicles
Mint Bangalore
|June 06, 2025
Our trust in AI makes us vulnerable to sponsored manipulation
Chatbots might hallucinate and flatter their users too much, but at least their subscription model is healthy for our well-being. Many Americans pay about $20 a month to use the premium versions of OpenAI's ChatGPT, Google's Gemini Pro or Anthropic's Claude. The result is that the products are designed to provide maximum utility.
Don't expect this status quo to last. Subscription revenue has a limit. Even the most popular models are under pressure to find new revenue streams. Unfortunately, the most obvious one is advertising—the web's most successful business model. AI builders are already exploring ways to plug more ads into their products, and while that's good for their bottom lines, it also means we're about to see a new chapter in the attention economy that fueled the internet.
If social media's descent into engagement-bait is any guide, the consequences will be profound.
One cost is addiction. OpenAI says a cohort of 'problematic' ChatGPT users are hooked on the tool. Putting ads into ChatGPT, which now has more than 500 million active users, won't spur the company to help those people reduce their use of the product. Quite the opposite.
यह कहानी Mint Bangalore के June 06, 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Mint Bangalore से और कहानियाँ
Mint Bangalore
A modern-day throwback to 'Malgudi Days'
Sita Bhaskar's latest novel revisits writer R.K. Narayan’s legacy to explore class, caste, and community in Mysuru
4 mins
December 13, 2025
Mint Bangalore
Come for the 'baithak', stay for the shopping
Fashion brands are hosting workshops, talks, music gigs and 'baithaks' to take a culture-first approach to customer loyalty
4 mins
December 13, 2025
Mint Bangalore
Novo Nordisk debuts Ozempic at ₹2,200 a week
Danish drugmaker Novo Nordisk on Friday launched its blockbuster diabetes drug Ozempic in India, with a starting price of ₹2,200 per week.
1 mins
December 13, 2025
Mint Bangalore
Tushar Adhav and politics of the dance floor
There's a 1983 song by English new wave band Re-Flex that keeps popping up in my mind every time I find myself on an Indian club floor.
4 mins
December 13, 2025
Mint Bangalore
English's place in history is not black and white
In 1784, two white men joined forces to establish an English school in Thanjavur, Tamil Nadu.
4 mins
December 13, 2025
Mint Bangalore
Rajasthan limits e-NAM 2.0 pilot amid snags; 1.0 to stay
The Centre restricted e-NAM 2.0 pilot to 10 mandis, including Tonk, Jodhpur and Sujangarh
3 mins
December 13, 2025
Mint Bangalore
GST cuts, easing inflation drive rural demand revival
India’s rural economy expanded and recovered strongly in late 2025, with consumption, incomes and investment improving after a key tax reform and as inflation eased, a survey showed.
2 mins
December 13, 2025
Mint Bangalore
Sebi weighs easier unified penalty rules for listed cos
Explores framework like the one for brokers that standardized and reduced fines
2 mins
December 13, 2025
Mint Bangalore
The loss of Srinagar as a cosmopolitan city
Sameer Hamdani's book brings alive the details that once defined life in one of South Asia's oldest cities but stops short of reflecting on the present
5 mins
December 13, 2025
Mint Bangalore
'We need 100 Earths to sustain generative Al'
Karen Hao, author of ‘Empire of AI’, explains how AI and tech companies are no less than extractive colonial empires
4 mins
December 13, 2025
Listen
Translate
Change font size
